Jaguar Health, Inc.
JAGX
|
$0.1772
7.46%
6.94%
68M
|
Health Technology
(0.0% 1d) (125.3% 1m) (-69.3% 1y) (0.0% 2d) (12.5% 3d) (51.5% 7d) (-48.25% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 48,945,521
http://www.jaguar.health
Sec Filling | Patents | 29 employees
(US) Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
diarrhea hiv gastrointestinal animals
add to watch list Paper trade email alert is off
Press-releases
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 7.14%
H: 1.11%
C: -8.89%
health granted extension
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -4.68%
H: 0.82%
C: 0.82%
health international
Jaguar Health Reports 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -14.35%
health financial results
Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief
Published: 2024-02-14 (Crawled : 15:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -0.24%
H: 1.1%
C: -0.73%
health direct
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 6.09%
H: 7.88%
C: 0.68%
fda drug diarrhea health designation application crofelemer submission
Jaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -3.2%
H: 0.37%
C: -4.13%
conference health microcap
A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -15.16%
H: 1.78%
C: -18.62%
diarrhea cancer trial therapy
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website
Published: 2023-12-06 (Crawled : 14:30) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 0.03%
H: 1.67%
C: -1.27%
breast health life symposium cancer pharmaceuticals family study
Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference
Published: 2023-11-30 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 1.83%
H: 7.34%
C: -0.84%
conference health
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10